{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:44:12Z","timestamp":1760057052108,"version":"build-2065373602"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Vlerick Academic Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-13426-w","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:48:49Z","timestamp":1760014129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["What drives patient cost variability in psoriasis care: a single centre study"],"prefix":"10.1186","volume":"25","author":[{"given":"Erin","family":"Roman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Roodhooft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elfie","family":"Deprez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brecht","family":"Cardoen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"13426_CR1","volume-title":"Redefining health care","author":"ME Porter","year":"2006","unstructured":"Porter ME, Teisberg EO. Redefining health care. Boston: Harvard Business School Publishing Corporation; 2006."},{"key":"13426_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMp0904131","volume":"361","author":"ME Porter","year":"2009","unstructured":"Porter ME. A strategy for health care reform \u2014 toward a value-based system. N Engl J Med. 2009;361:109\u201312.","journal-title":"N Engl J Med"},{"key":"13426_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1056\/NEJMp1011024","volume":"363","author":"ME Porter","year":"2010","unstructured":"Porter ME. What is value in health care? N Engl J Med. 2010;363:5.","journal-title":"N Engl J Med"},{"key":"13426_CR4","first-page":"1","volume":"1277","author":"ME Porter","year":"2013","unstructured":"Porter ME, Lee TH. The strategy that will fix healthcare. Harv Bus Rev. 2013;1277:1\u201319.","journal-title":"Harv Bus Rev"},{"key":"13426_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.healthpol.2021.12.004","volume":"126","author":"K Jacobs","year":"2022","unstructured":"Jacobs K, Roman E, Lambert J, et al. Variability drivers of treatment costs in hospitals: a systematic review. Health Policy. 2022;126:75\u201386.","journal-title":"Health Policy"},{"key":"13426_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3109\/09546634.2015.1117566","volume":"27","author":"E DeCoster","year":"2016","unstructured":"DeCoster E, Alves de Medeiros A, Bostoen J, et al. A multileveled approach in psoriasis assessment and follow-up: a proposal for a tailored guide for the dermatological practice. J Dermatol Treat. 2016;27:298\u2013310.","journal-title":"J Dermatol Treat"},{"key":"13426_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2004.02310.x","volume":"135","author":"JE Gudjonsson","year":"2004","unstructured":"Gudjonsson JE, Johnston A, Sigmundsdottir H, et al. Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol. 2004;135:1\u20138.","journal-title":"Clin Exp Immunol"},{"key":"13426_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.autrev.2006.12.002","volume":"6","author":"P Gisondi","year":"2007","unstructured":"Gisondi P, Girolomoni G. Biologic therapies in psoriasis: a new therapeutic approach. Autoimmun Rev. 2007;6:515\u20139.","journal-title":"Autoimmun Rev"},{"key":"13426_CR9","doi-asserted-by":"crossref","unstructured":"Chiu M, Ni C. Psoriasis and comorbidities: links and risks. CCID. 2014;7:119-132.","DOI":"10.2147\/CCID.S44843"},{"key":"13426_CR10","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.jaad.2015.02.1099","volume":"72","author":"J Vanderpuye-Orgle","year":"2015","unstructured":"Vanderpuye-Orgle J, Zhao Y, Lu J, et al. Evaluating the economic burden of psoriasis in the United States. J Am Acad Dermatol. 2015;72:961-967.e5.","journal-title":"J Am Acad Dermatol"},{"key":"13426_CR11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.2310\/7750.2009.08068","volume":"13","author":"B Chan","year":"2009","unstructured":"Chan B, Hales B, Shear N, et al. Work-related lost productivity and its economic impact on Canadian patients with moderate to severe psoriasis. J Cutan Med Surg. 2009;13:192\u20137.","journal-title":"J Cutan Med Surg"},{"key":"13426_CR12","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/jdv.12572","volume":"29","author":"T Hawro","year":"2015","unstructured":"Hawro T, Zalewska A, Hawro M, et al. Impact of psoriasis severity on family income and quality of life. J Eur Acad Dermatol Venereol. 2015;29:438\u201343.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"131\u20138","key":"13426_CR13","first-page":"150","volume":"82","author":"R Kaplan","year":"2004","unstructured":"Kaplan R, Anderson S. Time-driven activity-based costing. Harv Bus Rev. 2004;82(131\u20138):150.","journal-title":"Harv Bus Rev"},{"key":"13426_CR14","first-page":"2011","volume":"89","author":"RS Kaplan","year":"2011","unstructured":"Kaplan RS, Porter ME. How to solve the cost crisis in health care. Harv Bus Rev. 2011;89:2011\u20133.","journal-title":"Harv Bus Rev"},{"key":"13426_CR15","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jval.2020.02.004","volume":"23","author":"APBDS Etges","year":"2020","unstructured":"Etges APBDS, Ruschel KB, Polanczyk CA, et al. Advances in value-based healthcare by the application of time-driven activity-based costing for inpatient management: a systematic review. Value Health. 2020;23:812\u201323.","journal-title":"Value Health"},{"key":"13426_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/2151459320958202","author":"BL Blaschke","year":"2020","unstructured":"Blaschke BL, Parikh HR, Vang SX, et al. Time-driven activity-based costing: a better way to understand the cost of caring for hip fractures. Geriatr Orthop Surg Rehabil. 2020. https:\/\/doi.org\/10.1177\/2151459320958202.","journal-title":"Geriatr Orthop Surg Rehabil"},{"key":"13426_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.hjdsi.2014.09.007","volume":"3","author":"AL Kaplan","year":"2015","unstructured":"Kaplan AL, Agarwal N, Setlur NP, et al. Measuring the cost of care in benign prostatic hyperplasia using time-driven activity-based costing (TDABC). Healthcare. 2015;3:43\u20138.","journal-title":"Healthcare"},{"key":"13426_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1108\/QRAM-04-2014-0036","volume":"11","author":"C Campanale","year":"2014","unstructured":"Campanale C, Cinquini L, Tenucci A. Time-driven activity-based costing to improve transparency and decision making in healthcare: a case study. Qual Res Account Manag. 2014;11:165\u201386.","journal-title":"Qual Res Account Manag"},{"issue":"7","key":"13426_CR19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/jamadermatol.2016.0502","volume":"152","author":"JS Kirby","year":"2016","unstructured":"Kirby JS, Delikat A, Leslie D, et al. Bundled payment models for actinic keratosis management. JAMA Dermatol. 2016;152:789.","journal-title":"JAMA Dermatol"},{"key":"13426_CR20","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1056\/NEJMp1011849","volume":"364","author":"JN Struijs","year":"2011","unstructured":"Struijs JN, Baan CA. Integrating care through bundled payments \u2014 lessons from the Netherlands. N Engl J Med. 2011;364:990\u20131.","journal-title":"N Engl J Med"},{"key":"13426_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1377\/hlthaff.2011.0912","volume":"31","author":"DH de Bakker","year":"2012","unstructured":"de Bakker DH, Struijs JN, Baan CA, et al. Early results from adoption of bundled payment for diabetes care in the Netherlands show improvement in care coordination. Health Aff. 2012;31:426\u201333.","journal-title":"Health Aff"},{"key":"13426_CR22","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1161\/STROKEAHA.115.009089","volume":"46","author":"DB Matchar","year":"2015","unstructured":"Matchar DB, Nguyen HV, Tian Y. Bundled payment and care of acute stroke: what does it take to make it work? Stroke. 2015;46:1414\u201321.","journal-title":"Stroke"},{"key":"13426_CR23","first-page":"406","volume":"41","author":"WF Whitcomb","year":"2015","unstructured":"Whitcomb WF, Lagu T, Krushell RJ, et al. Experience with designing and implementing a bundled payment program for total hip replacement. Jt Comm J Qual Patient Saf. 2015;41:406\u201313.","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"13426_CR24","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1377\/hlthaff.2012.0368","volume":"31","author":"S Swaminathan","year":"2012","unstructured":"Swaminathan S, Mor V, Mehrotra R, et al. Medicare\u2019s payment strategy for end-stage renal disease now embraces bundled payment and pay-for-performance to cut costs. Health Aff. 2012;31:2051\u20138.","journal-title":"Health Aff"},{"key":"13426_CR25","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1159\/000455840","volume":"232","author":"P Jensen","year":"2016","unstructured":"Jensen P, Skov L. Psoriasis and obesity. Dermatology. 2016;232:633\u20139.","journal-title":"Dermatology"},{"key":"13426_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1087-0024.2004.09113.x","volume":"9","author":"V Lewis","year":"2004","unstructured":"Lewis V, Finlay AY. 10 years experience of the dermatology life quality index (DLQI). J Invest Dermatol Symp Proc. 2004;9:169\u201380.","journal-title":"J Invest Dermatol Symp Proc"},{"key":"13426_CR27","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/07434610902744066","volume":"33","author":"MHA Fadzil","year":"2009","unstructured":"Fadzil MHA, Ihtatho D, Affandi AM, et al. Area assessment of psoriasis lesions for PASI scoring. J Med Eng Technol. 2009;33:426\u201336.","journal-title":"J Med Eng Technol"},{"issue":"a","key":"13426_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1177\/247553031117a00403","volume":"17","author":"RV Patel","year":"2011","unstructured":"Patel RV, Tsui CL. Evaluating psoriasis: a review of the assessments most commonly used in clinical trials. Psoriasis Forum. 2011;17(a):259\u201366.","journal-title":"Psoriasis Forum"},{"key":"13426_CR29","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/jdv.12576","volume":"29","author":"D H\u00e4gg","year":"2015","unstructured":"H\u00e4gg D, Sundstr\u00f6m A, Eriksson M, et al. Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI). J Eur Acad Dermatol Venereol. 2015;29:452\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"13426_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkaa033","volume":"4","author":"J Rech","year":"2020","unstructured":"Rech J, Sticherling M, Stoessel D, et al. Psoriatic arthritis epidemiology, comorbid disease profiles and risk factors: results from a claims database analysis. Rheumatol Adv Pract. 2020;4:rkaa033.","journal-title":"Rheumatol Adv Pract"},{"key":"13426_CR31","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1046\/j.1365-2230.2001.00834.x","volume":"26","author":"CEM Griffiths","year":"2001","unstructured":"Griffiths CEM, Richards HL. Psychological influences in psoriasis: psychological influences in psoriasis. Clin Exp Dermatol. 2001;26:338\u201342.","journal-title":"Clin Exp Dermatol"},{"key":"13426_CR32","doi-asserted-by":"publisher","unstructured":"Porumb\u2011Andrese E, V\u00e2\u021b\u0103 D, Postolic\u0103 R, et al. Association between personality type, affective distress profile and quality of life in patients with psoriasis vs. patients with cardiovascular disease. Exp Ther Med. Epub ahead of print 21 August 2019. https:\/\/doi.org\/10.3892\/etm.2019.7933.","DOI":"10.3892\/etm.2019.7933"},{"key":"13426_CR33","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/jdv.12174","volume":"28","author":"A Bewley","year":"2014","unstructured":"Bewley A, Burrage DM, Ersser SJ, et al. Identifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two-stage qualitative and quantitative study. Acad Dermatol Venereol. 2014;28:763\u201370.","journal-title":"Acad Dermatol Venereol"},{"key":"13426_CR34","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ad.2016.04.018","volume":"107","author":"R Burgos-Pol","year":"2016","unstructured":"Burgos-Pol R, Mart\u00ednez-Sesmero JM, Ventura-Cerd\u00e1 JM, et al. The cost of psoriasis and psoriatic arthritis in 5 European countries: a systematic review. Actas Dermo-Sifiliogr. 2016;107:577\u201390.","journal-title":"Actas Dermo-Sifiliogr"},{"key":"13426_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-09258-1","volume":"23","author":"J Evans","year":"2023","unstructured":"Evans J, Leggat SG, Samson D. A systematic review of the evidence of how hospitals capture financial benefits of process improvement and the impact on hospital financial performance. BMC Health Serv Res. 2023;23:237.","journal-title":"BMC Health Serv Res"},{"key":"13426_CR36","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1080\/13696998.2018.1472097","volume":"21","author":"MJ Murage","year":"2018","unstructured":"Murage MJ, Anderson A, Oliveria SA, et al. Healthcare resource utilization and costs among psoriasis patients treated with biologics, overall and by disease severity. J Med Econ. 2018;21:745\u201354.","journal-title":"J Med Econ"},{"key":"13426_CR37","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jaad.2008.06.043","volume":"59","author":"JF Fowler","year":"2008","unstructured":"Fowler JF, Duh MS, Rovba L, et al. The impact of psoriasis on health care costs and patient work loss. J Am Acad Dermatol. 2008;59:772\u201380.","journal-title":"J Am Acad Dermatol"},{"key":"13426_CR38","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/j.1526-4610.2006.00428.x","volume":"46","author":"JF Rothrock","year":"2006","unstructured":"Rothrock JF, Parada VA, Sims C, et al. The impact of intensive patient education on clinical outcome in a clinic-based migraine population. Headache. 2006;46:726\u201331.","journal-title":"Headache"},{"key":"13426_CR39","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1097\/ACM.0b013e3181f4ab3c","volume":"85","author":"MA Dinan","year":"2010","unstructured":"Dinan MA, Simmons LA, Snyderman R. Commentary: Personalized health planning and the patient protection and affordable care act: An opportunity for academic medicine to lead health care reform. Acad Med. 2010;85:1665\u20138.","journal-title":"Acad Med"},{"key":"13426_CR40","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/jpm2040232","volume":"2","author":"R Burnette","year":"2012","unstructured":"Burnette R, Simmons L, Snyderman R. Personalized health care as a pathway for the adoption of genomic medicine. JPM. 2012;2:232\u201340.","journal-title":"JPM"},{"key":"13426_CR41","first-page":"27","volume":"33","author":"LA Simmons","year":"2016","unstructured":"Simmons LA, Drake CD, Gaudet TW, et al. Personalized health planning in primary care settings. Fed Pract. 2016;33:27.","journal-title":"Fed Pract"},{"key":"13426_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/gm533","volume":"6","author":"L Simmons","year":"2014","unstructured":"Simmons L, Wolever RQ, Bechard EM, et al. Patient engagement as a risk factor in personalized health care: a systematic review of the literature on chronic disease. Genome Med. 2014;6:16.","journal-title":"Genome Med"},{"key":"13426_CR43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1377\/hlthaff.2012.1061","volume":"32","author":"JH Hibbard","year":"2013","unstructured":"Hibbard JH, Greene J. What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Aff. 2013;32:207\u201314.","journal-title":"Health Aff"},{"key":"13426_CR44","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/ced\/llad272","volume":"48","author":"MT Svendsen","year":"2023","unstructured":"Svendsen MT, Andersen KE, Feldman SR, et al. An effective patient-supporting intervention for topical treatment of psoriasis is also cost-effective. Clin Exp Dermatol. 2023;48:1247\u201354.","journal-title":"Clin Exp Dermatol"},{"key":"13426_CR45","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/bjd.13486","volume":"172","author":"MP Hamilton","year":"2015","unstructured":"Hamilton MP, Ntais D, Griffiths CEM, et al. Psoriasis treatment and management \u2013 a systematic review of full economic evaluations. Br J Dermatol. 2015;172:574\u201383.","journal-title":"Br J Dermatol"},{"key":"13426_CR46","first-page":"88","volume":"94","author":"ME Porter","year":"2016","unstructured":"Porter ME, Kaplan RS. How to pay for health care. Harv Bus Rev. 2016;94:88\u2013134.","journal-title":"Harv Bus Rev"},{"key":"13426_CR47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10198-008-0101-x","volume":"10","author":"SS Tan","year":"2009","unstructured":"Tan SS, Rutten FFH, Van Ineveld BM, et al. Comparing methodologies for the cost estimation of hospital services. Eur J Health Econ. 2009;10:39\u201345.","journal-title":"Eur J Health Econ"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13426-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-13426-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13426-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T14:06:08Z","timestamp":1760018768000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-13426-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13426"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-13426-w","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"13 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The \u2018Commissie voor Medische Ethiek U(Z) Gent\u2019 \u2013 the ethical committee of the hospital approved this study (ONZ-2022-0518). Informed consent was not required as we used anonymized data from patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1343"}}